The best-studied genetic mutation associated with the development of PAH is an alteration in BMPR2, the gene encoding bone morphogenetic protein receptor type 2, which is a member of the transforming growth factor-β (TGF-β) superfamily (55, 56). The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.